Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythaemia vera

Platelets

Volumn 20, Issue 4, 2009, Pages 282-287

  Udvardy, Miklos ^a   Toth, Judit ^a   Kappelmayer, Janos ^a   Udvardy, Miklos L ^a   Szanto, Timea ^a   Szarvas, Mariann ^a   Rejto, Laszlo ^a   Soltesz, Pal ^b   Harsfalvi, Jolan ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cerebral ischaemia; Cerebrovascular thrombotic manifestations; Glycoprotein (GP) Ib receptor; Platelet adhesion; Polycythaemia vera (PV); Von Willebrand factor (VWF)

Indexed keywords

GLYCOPROTEIN IB; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD VISCOSITY; BRAIN ISCHEMIA; CASE REPORT; FEMALE; HUMAN; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SHEAR RATE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOGENESIS;

ADULT; BRAIN ISCHEMIA; CELLS, CULTURED; HUMANS; MALE; PLATELET ADHESIVENESS; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; POLYCYTHEMIA VERA;

EID: 67651176015     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100902878421     Document Type: Article

References (25)

1. Beutler E. Polycythemia, In: Beutler ECB, Lichtman M, Kipps TJ, Seligsohn U, editors. Hematology, 6th ed., New York: McGraw-Hill; 2001. pp 689-701.
2. Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005;128:275-290.
3. Rao A. Acquired disorders of platelet function, In: Michelson A, editor. Platelets, 1st ed., New York: New York Academic Press; 2002.
4. Wehmeier A, Sudhoff T, Meierkord F. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders. Semin Thromb Hemost 1997;23: 391-402.
5. Michiels JJ. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: A distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts. Pathol Biol (Paris) 2003;51:167-175.
6. Michiels JJ, Berneman Z, Schroyens W. et al. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: A distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Platelets 2006;17:528-544.
7. Kerenyi A, Schlammadinger A, Ajzner E. et al. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function. Thromb Res 1999;96:487-492.
8. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981;57: 1140-1143.
9. Lorez HP, Da Prada M, Rendu F, Pletscher A. Mepacrine, a tool for investigating the 5-hydroxytryptamine organelles of blood platelets by fluorescence microscopy. J Lab Clin Med 1977;89:200-206.
10. Ginsberg MH, Frelinger AL, Lam SC. et al. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformationspecific monoclonal antibodies. Blood 1990;76:2017-2023.
11. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998;187:329-339.
12. Szarvas M, Oparaugo P, Udvardy ML. et al. Differential platelet deposition onto collagen in cone-and-plate and parallel plate flow chambers. Platelets 2006;17:185-190.
13. Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC. Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders. Br J Haematol 2000;110:116-124.
14. Mazzucato M, De Marco L, De Angelis V, De Roia D, Bizzaro N, Casonato A. Platelet membrane abnormalities in myeloproliferative disorders: Decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor function. Br J Haematol 1989;73:369-374.
15. Villmow T, Kemkes-Matthes B, Matzdorff AC. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Res 2002;108:139-145.
16. Tsuji S, Sugimoto M, Kuwahara M. et al. Role and initiation mechanism of the interaction of glycoprotein Ib with surface-immobilized von Willebrand factor in a solid-phase platelet cohesion process. Blood 1996;88:3854-3861.
17. Budde U, Dent JA, Berkowitz SD, Ruggeri ZM, Zimmerman TS. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome. Blood 1986;68:1213-1217.
18. Castaman G, Lattuada A, Ruggeri M, Tosetto A, Mannucci PM, Rodeghiero F. Platelet von Willebrand factor abnormalities in myeloproliferative syndromes. Am J Hematol 1995;49:289-293.
19. Fabris F, Casonato A, Grazia del Ben M, De Marco L, Girolami A. Abnormalities of von Willebrand factor in myeloproliferative disease: A relationship with bleeding diathesis. Br J Haematol 1986;63:75-83.
20. Mohri H, Ohkubo T. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera. Acta Haematol. 1987;78: 258-264.
21. Sanchez-Luceros A, Meschengieser SS, Woods AI. et al. Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: A retrospective analysis by a single institution. Haematologica 2002;87:264-270.
22. Avram S, Lupu A, Angelescu S, Olteanu N, Mut-Popescu D. Abnormalities of platelet aggregation in chronic myeloproliferative disorders. J Cell Mol Med 2001;5:79-87.
23. Lofvenberg E, Nilsson TK. Qualitative platelet defects in chronic myeloproliferative disorders: Evidence for reduced ATP secretion. Eur J Haematol 1989;43:435-440.
24. Pareti FI, Capitanio A, Mannucci L, Ponticelli C, Mannucci PM. Acquired dysfunction due to the circulation of "exhausted" platelets. Am J Med 1980;69:235-240.
25. Vannucchi AM, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, Marfisi RM, Finazzi G, Guerini V, Fabris F, Randi ML. et al. Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 2007;110:840-846.